Cookie Policy

We've put some small files called essential cookies on your device to help our site work on your browser.
We also use analytical cookies to help up improve our website by collecting and reporting information on it's usage.

You can read more above this on our Privacy Policy page.

I'm ok with analytical cookies Do not use analytics cookies

Analyst Coverage

Analyst Coverage

The following analysts currently issue reports on Shield Therapeutics:


Company Analyst
finnCap Mark Brewer
Peel Hunt Dr Miles Dixon
Edison Karl Egeland
Hardman & Co Dr Martin Hall
Capital Network / Proactive Investors Dr John Savin

All of finnCap, Edison, Hardman & Co and Capital Network’s research on their corporate clients are free to view via the following links:

finnCap – There is a simple registration process for all non-institutional users and their corporate research is readily available:


Hardman & Co

Capital Network/ Proactive Investors

Any opinions estimates or forecasts regarding the Company’s performance made by such analysts are theirs alone and do not represent opinions, forecasts or predictions of the Company or its Management. You should, therefore, not place undue reliance on the content of any such analyst report or statement.

Any reports issued may have become out of date following publication and should be read accordingly.